.team-manager-free-main-area-2218 { display: block; overflow: hidden; } .team-manager-free-main-area-2218 .team-manager-free-container{ display: -webkit-box; display: -ms-flexbox; display: flex; -ms-flex-wrap: wrap; flex-wrap: wrap; } .team-manager-free-main-area-2218 .team-manager-free-items { background: #fbfbfb; text-align:default; } .team-manager-free-main-area-2218 .team-manager-free-items i{ padding-right:5px; } .team-manager-free-main-area-2218 .team-manager-free-items-thumb a { border: medium none; border-radius: 0; box-shadow: none; outline: medium none; text-decoration: none; } .team-manager-free-main-area-2218 .team-manager-free-items-description{ padding:15px; } .team-manager-free-main-area-2218 .team-manager-free-items-thumb { position: relative; overflow: hidden; line-height: 0; } .team-manager-free-main-area-2218 .team-manager-free-items-thumb img{ width: 100%; height: auto; transition: all 0.3s ease-in-out; } /* Zoom In */ .team-manager-free-main-area-2218 .team-manager-free-items:hover .team-manager-free-items-thumb img { transform: scale(1.10); } .team-manager-free-main-area-2218 .tmf-member-title, .team-manager-free-main-area-2218 .tmf-member-title a{ margin: 0px; overflow: hidden; color: #007acc; font-size: 15px; text-transform: unset; outline: medium none; text-decoration: none; box-shadow: none; } .team-manager-free-main-area-2218 .tmf-member-title a:hover{ color:#333333; } .team-manager-free-main-area-2218 .tmf-designation{ display:block; color: #333333; font-size: 12px; font-style: normal; text-transform: unset; margin-bottom: 10px; }
Pronouns: he/him/his Dr. Lehmler is a Professor at the College of Public Health and has served as the EHSRC Director since 2020. Prior to that time, he was the EHSRC Deputy Director. Dr. Lehmler is an experienced environmental health scientist and highly qualified research grant administrator. In addition to his role as EHSRC Director, Dr. Lehmler is among the leadership team of the Exposure Science Facility and serves as the director of the Career Enhancement Program. He leads a joint seminar series that regularly brings together faculty, staff, and students of the EHSRC and the Interdisciplinary Graduate Program in Human Toxicology. Additionally, he oversees the activities of the Water Quality thematic area together with Dr. David Cwiertny. His NIEHS-funded research employs novel animal models, including germ-free mice and transgenic animals, to characterize how the metabolism of chemical hazards, such as polychlorinated biphenyls (PCBs), affects neurotoxic outcomes across the lifespan. These studies bring together investigators from the UC Davis Environmental Health Sciences Core Center, the Center for Exposures, Diseases, Genomics, and Environment (EDGE) at the University of Washington, and the Southwest Environmental Health Sciences Center (SWEHSC) at the University of Arizona. Dr. Lehmler also serves as Deputy Director of the Iowa Superfund Research Program under the direction of Dr. Keri Hornbuckle. Under this program, Dr. Lehmler leads a Research Project investigating the neurotoxicity of inhaled PCBs in adolescents. This Research Project brings together several EHSRC researchers, including Hanna Stevens and Jonathan Doorn, to study how adolescent exposure to airborne PCBs is mechanistically linked to altered neurodevelopmental outcomes through mitochondrial dysfunction in astrocytes. Dr. Lehmler also leads the Synthesis Core of the Iowa Superfund Research Program and is a member of the leadership team of the Analytical Core. Janssen is a Clinical Professor in the Department of Occupational and Environmental Health. Trained as a cultural anthropologist, she has extensive experience in qualitative and ethnographic methods and community engaged research in rural spaces, particularly focusing on agriculture, food systems, and environmental health. Janssen transitioned to the role of Deputy Director in 2025. She has served as Director of the EHSRC Community Engagement Core (CEC) since 2018 and as Director of Undergraduate Programs in the College of Public Health since 2022. As CEC Director, Janssen led a regional environmental health needs assessment, which collected data about environmental health concerns, trusted information sources, and disaster preparedness across Iowa, Nebraska, Kansas and Missouri. She oversees the development of environmental health resources for rural communities and multi-media products, including the Iowa Environmental Health Podcast. In addition, Janssen is the lead PI of Central Midwest COLEARN, a NOAA RISA team (NA23OAR4310629). In this role, she work with rural residents across Iowa, Nebraska, Kansas, and Missouri identifying community-based needs related to extreme weather preparedness to deliver appropriate programming. Overall, Janssen's integrative approach emphasizes a holistic and community-based perspective that takes into account the complex cultural interactions that underlie rural environmental challenges.
Professor of Occupational and Environmental Health; Center Director; Co-Leader, Water Quality Thematic Area (WQ-TA)
Hans-Joachim Lehmler, PhD
Clinical Professor of Occupational and Environmental Health; Center Deputy Director; Community Engagement Core Director; Co-Leader, Population Health Thematic Area (PH-TA)
Brandi Janssen, PhD
.team-manager-free-main-area-2224 { display: block; overflow: hidden; } .team-manager-free-main-area-2224 .team-manager-free-container{ display: -webkit-box; display: -ms-flexbox; display: flex; -ms-flex-wrap: wrap; flex-wrap: wrap; } .team-manager-free-main-area-2224 .team-manager-free-items { background: #fbfbfb; text-align:default; } .team-manager-free-main-area-2224 .team-manager-free-items i{ padding-right:5px; } .team-manager-free-main-area-2224 .team-manager-free-items-thumb a { border: medium none; border-radius: 0; box-shadow: none; outline: medium none; text-decoration: none; } .team-manager-free-main-area-2224 .team-manager-free-items-description{ padding:15px; } .team-manager-free-main-area-2224 .team-manager-free-items-thumb { position: relative; overflow: hidden; line-height: 0; } .team-manager-free-main-area-2224 .team-manager-free-items-thumb img{ width: 100%; height: auto; transition: all 0.3s ease-in-out; } /* Zoom In */ .team-manager-free-main-area-2224 .tmf-member-title, .team-manager-free-main-area-2224 .tmf-member-title a{ margin: 0px; overflow: hidden; color: #007acc; font-size: 15px; text-transform: unset; outline: medium none; text-decoration: none; box-shadow: none; } .team-manager-free-main-area-2224 .tmf-member-title a:hover{ color:#333333; } .team-manager-free-main-area-2224 .tmf-designation{ display:block; color: #333333; font-size: 12px; font-style: ; text-transform: unset; margin-bottom: 10px; }
Pronouns: he/him/his Dr. Lehmler is a Professor at the College of Public Health and has served as the EHSRC Director since 2020. Prior to that time, he was the EHSRC Deputy Director. Dr. Lehmler is an experienced environmental health scientist and highly qualified research grant administrator. In addition to his role as EHSRC Director, Dr. Lehmler is among the leadership team of the Exposure Science Facility and serves as the director of the Career Enhancement Program. He leads a joint seminar series that regularly brings together faculty, staff, and students of the EHSRC and the Interdisciplinary Graduate Program in Human Toxicology. Additionally, he oversees the activities of the Water Quality thematic area together with Dr. David Cwiertny. His NIEHS-funded research employs novel animal models, including germ-free mice and transgenic animals, to characterize how the metabolism of chemical hazards, such as polychlorinated biphenyls (PCBs), affects neurotoxic outcomes across the lifespan. These studies bring together investigators from the UC Davis Environmental Health Sciences Core Center, the Center for Exposures, Diseases, Genomics, and Environment (EDGE) at the University of Washington, and the Southwest Environmental Health Sciences Center (SWEHSC) at the University of Arizona. Dr. Lehmler also serves as Deputy Director of the Iowa Superfund Research Program under the direction of Dr. Keri Hornbuckle. Under this program, Dr. Lehmler leads a Research Project investigating the neurotoxicity of inhaled PCBs in adolescents. This Research Project brings together several EHSRC researchers, including Hanna Stevens and Jonathan Doorn, to study how adolescent exposure to airborne PCBs is mechanistically linked to altered neurodevelopmental outcomes through mitochondrial dysfunction in astrocytes. Dr. Lehmler also leads the Synthesis Core of the Iowa Superfund Research Program and is a member of the leadership team of the Analytical Core. Dr. Adamcakova-Dodd serves as Director of the Pulmonary Toxicology Facility (PTF) within the Environmental Health Sciences Research Center (EHSRC). She leads interdisciplinary research focused on adverse outcomes following inhaled environmental and occupational exposures. Her earlier research focused on the epidemiology of allergic diseases among children in relation to environmental factors including placental contamination by heavy metals or polychlorinated biphenyls (PCBs). Dr. Adamcakova-Dodd joined the PTF in 2002 and has since led and collaborated on studies evaluating the toxicity of a wide range of inhaled agents, including particulate aerosols (metal and metal oxide nanoparticles and carbon nanotubes), vapors (PCBs), metalworking fluids, endotoxin, biological aerosols containing pathogenic microorganisms, and toxic gases (sulfur dioxide, chlorine, and phosphine). She has extensive experience designing and conducting toxicological studies using both in vitro models, including air–liquid interface systems, and in vivo models with the assessment of a broad range of toxicological, biological, and functional endpoints. Her research experience includes the development and application of diverse models of pulmonary injury and disease, including inflammation induced by endotoxin or particulate matter, allergic asthma induced by house dust mite allergen, hypersensitivity pneumonitis associated with metalworking fluids, pulmonary fibrosis induced by bleomycin or crystalline silica, and acute lung injury resulting from exposure to toxic gases. Recent areas of research emphasis include the inhalation toxicology of emerging contaminants such as micro- and nanoplastics, the development of medical countermeasures against chemical threat agents, and the elucidation of extracellular vesicle-mediated mechanisms involved in the initiation, progression, and resolution or persistence of pulmonary inflammation. A particular focus of her research is identifying specific miRNAs involved in the resolution of pulmonary inflammation and evaluating their potential as therapeutic agents following exposure to toxic inhaled aerosols or gases. Through the PTF, she provides scientific and strategic leadership, develops research capabilities, facilitates multidisciplinary collaborations, and supports investigators in the design, execution, and interpretation of pulmonary toxicology studies. She is also committed to mentoring graduate students, postdoctoral fellows, and research staff. Dr. Cho is a pulmonologist and Co-Leader of the EHSRC's Inflammation and Innate Immunity Thematic Area (III-TA). She leads a basic and translational immunology research program focused on understanding the pathogenesis of inflammatory lung diseases. Using both mouse and human models of disease, her laboratory investigates the contributions of innate and adaptive immune responses to allergic asthma, smoking- and vaping-related diseases, and respiratory viral infection. Selected Publications: Dr. Comellas is a Clinical Professor in the Division of Pulmonary, Critical Care, and Occupational Medicine; Director of Clinical Research Support for the Institute for Clinical and Translational Science (ICTS); and Director of the Translational Research Support Core for the Environmental Health Sciences Research Center (EHSRC) at the University of Iowa . His research integrates mechanistic, clinical, and imaging-based approaches to understand lung injury and chronic respiratory disease. A major focus of his current work is the use of quantitative CT, advanced image analysis, and artificial intelligence to characterize small-airways disease, emphysema, vascular abnormalities, and extrapulmonary manifestations of COPD and post-acute COVID-19. Through leadership and collaboration in large multicenter studies, including SPIROMICS and COPDGene, Dr. Comellas aims to identify imaging and biologic phenotypes that improve early detection, risk stratification, and personalized treatment of smoking-related and environmentally mediated lung disease. Dr. Cwiertny’s research program broadly focuses on pollutant fate in natural and engineered aquatic systems, relying on complementary tools from engineering, chemistry and materials science. He has specific expertise related to the (i) environmental fate and risk assessment of emerging pollutant classes, and (ii) development of (nano)material-based technologies for resource sustainability. In particular, his work often focuses on issues at the intersection of environmental quality with public health and public policy. In October of 2017, Dr. Cwiertny was appointed Director for the Center of Health Effects of Environmental Contamination (CHEEC), a state-sponsored research center focused on improving the environmental quality and public health of Iowans. At the EHSRC, Dr. Cwiertny co-leads the Water Quality Thematic Area (WQ-TA), coordinating activities among EHSRC members across three colleges (Public Health, Engineering, and Liberal Arts and Science) with research expertise in water quality and health impacts associated with water contamination. Between 2015 and 2023, Dr. Cwiertny served as the Director of the Environmental Policy Research Program at the UI Public Policy Center (UI PPC). In 2016-2017, he served as an American Association for the Advancement of Science (AAAS) Congressional Fellow, working as minority staff for the House of Representatives Committee on Energy and Commerce and its subcommittees on Energy and Environment. Dr. Doorn’s research program is focused on elucidating mechanisms of neurotoxicity relevant to neurodegenerative disease with particular attention to the role of environmental contaminants. Of particular interest is the role of environmental organochlorines, e.g., polychlorinated biphenyls (PCBs), dieldrin, and organophosphates in generating toxic conditions in vitro/in vivo that adversely modulate dopaminergic and glial cells, work highly relevant to neurodegenerative and neurodevelopmental conditions. Recent work examined the role of the organochlorine dieldrin in stressing dopaminergic cells to produce elevated levels of a toxic dopamne metabolite (i.e., 3,4-dihydroxyphenylacetaldehyde). In collaboration with the Iowa Superfund Research Program and Drs. Hans Lehmler and Hanna Stevens, Dr. Doorn has shown that PCBs and their human relevant metabolites target astrocyte mitochondria yielding a bioenergetic crisis, in particular a specific congener (PCB52 and its metabolites). In addition, he is interested in the role of natural product analogs in eliciting a protective response and collaborating with Drs. David Martin and Marie Gaine on a drug discovery project that focuses on the NRF2-KEAP1 system and neuroprotection against agents such as organophosphates. Dr. Eric A. Hoffman, Ph.D. received his Ph.D. in Physiology from the University of Minnesota / Mayo Graduate School of Medicine in 1981 and remained on staff at the Mayo Clinic where he was a member of the team which Developed the Dynamic Spatial Reconstructor (DSR), the earliest volumetric X-Ray computed tomographic scanner. He currently is the director of the Advanced Pulmonary Physiomics Laboratory (APPIL) at the University of Iowa. Throughout his career, Dr. Hoffman has used advanced imaging methodologies to study basic respiratory physiology centered largely on mechanisms of ventilation and perfusion heterogeneity and regional lung mechanics. In the late 1970s, volumetric computed tomography was used to provide a first look at regional lung mechanics in the never invaded negative pressure environment of the intact thorax. Hoffman’s contributions have served to illuminate many underlying relationships in COPD, Asthma and environmental lung diseases. Recent work has led to the investigation of vascular dysfunction in the etiology of emphysema based upon novel uses of dual energy multidetector row CT (DECT). A key contribution of Dr. Hoffman’s work lies in the continued efforts to provide analysis tools, coordination, quality control and image analysis to support NIH sponsored multi-center studies (NETT, MESA Lung, SPIROMICS, SARP, PrecISE, etc.) whereby imaging of the lung serves to explore novel phenotypes or to provide outcomes measures related to interventions. The APPIL laboratory includes a research dedicated, state-of-the-art photon-counting CT scanner (Siemens Naeotom Alpha) supported, in part, through an NIH high-end shared instrumentation grant. Janssen is a Clinical Professor in the Department of Occupational and Environmental Health. Trained as a cultural anthropologist, she has extensive experience in qualitative and ethnographic methods and community engaged research in rural spaces, particularly focusing on agriculture, food systems, and environmental health. Janssen transitioned to the role of Deputy Director in 2025. She has served as Director of the EHSRC Community Engagement Core (CEC) since 2018 and as Director of Undergraduate Programs in the College of Public Health since 2022. As CEC Director, Janssen led a regional environmental health needs assessment, which collected data about environmental health concerns, trusted information sources, and disaster preparedness across Iowa, Nebraska, Kansas and Missouri. She oversees the development of environmental health resources for rural communities and multi-media products, including the Iowa Environmental Health Podcast. In addition, Janssen is the lead PI of Central Midwest COLEARN, a NOAA RISA team (NA23OAR4310629). In this role, she work with rural residents across Iowa, Nebraska, Kansas, and Missouri identifying community-based needs related to extreme weather preparedness to deliver appropriate programming. Overall, Janssen's integrative approach emphasizes a holistic and community-based perspective that takes into account the complex cultural interactions that underlie rural environmental challenges. Dr. Keating’s research group studies phenotypic outcomes and mechanisms of action induced by environmental ovotoxicant exposures. In addition, they have discovered that alterations to physiological status (heat stress, obesity) can be additive to the negative effects of ovotoxic chemical exposures. The ultimate goal of her studies is to identify and develop intervention strategies to ameliorate the negative reproductive impacts of ovotoxicant exposure and improve female health. Jong Sung Kim is an Associate Professor of Occupational & Environmental Health in the University of Iowa College of Public Health. He serves as Director of the UI Human Toxicology Program (HTP) and the EHSRC's Pilot Grant Program. His interdisciplinary research integrates environmental chemistry, toxicology, exposure science, and human biomonitoring to understand the health effects of environmental and occupational exposures. Kim's research focuses on inhalation toxicology, metals and metallomics, and emerging contaminants, including tire-wear associated particles and chemicals, nanoparticles and micro- and nanoplastics. His laboratory combines advanced analytical approaches, including mass spectrometry, metallomics, and chemical exposome profiling, with inhalation toxicology using in vitro air-liquid interface (ALI) models and in vivo inhalation studies to characterize exposure, biological responses, and mechanisms of toxicity. His work has advanced ALI approaches for investigating airborne particles and particle-contaminant interactions and contributed to the development and application of toenail biomarkers for assessing cumulative exposure to metals in population-based studies. More recently, his research integrates metallomics with untargeted high-resolution mass spectrometry to identify biomarkers of environmental exposure, susceptibility, and disease risk. Kim collaborates broadly across epidemiology, chemistry, engineering, exposure science, and clinical disciplines to address emerging environmental health challenges. Through his leadership of the EHSRC Pilot Grant Program, he fosters interdisciplinary research and supports early-stage investigators in developing innovative environmental health research into competitive, independently funded programs. He is also deeply committed to graduate education and mentorship through his leadership of the Human Toxicology Program. Dr. McCray has a long-standing interest in the pathogenesis and treatment of cystic fibrosis. His laboratory has two main areas of investigation: 1) pulmonary host defense, and 2) gene transfer for the treatment of inherited diseases. Work in the lab is supported by the NIH and the Cystic Fibrosis Foundation. Dr. O'Shaughnessy directs the EHSRC's Exposure Science Facility (ESF). Dr. O’Shaughnessy was educated as an environmental engineer with expertise in the simulation of the dispersion of contaminants near a pollution source, exposure assessment methods, as well as the assessment of aerosol and gas sensors. As the ESF director, he has counseled multiple Center investigators and pilot grant awardees concerning proper assessment methods for aerosol and gas exposures and has gained substantial knowledge of the related projects and outcomes as a result. Dr. O’Shaughnessy has a long-standing reputation in the field of industrial hygiene as an expert in aerosol exposure assessment, the evaluation of sampling devices for nanoparticle detection, the factors that affect the efficacy of respirators, and the use of air dispersion modeling to investigate the health effect of ambient air pollutants on nearby populations. Recent studies have focused on the plumes of dust emitted by passing cars traveling on rural gravel roads and their potential to aggravate pulmonary conditions among nearby residents. Dr. Salem’s research expertise encompasses drug discovery, development, formulation, and delivery. He applies this expertise to develop therapies for cancer and other diseases and to advance regenerative medicine. His laboratory investigates how cancer develops and designs new strategies for cancer treatment, including approaches that use polymer particle technology, CpG oligonucleotides, and adenoviruses to generate stronger and more sustained antitumor immune responses. He also conducts federally funded investigations that evaluate the toxicity of chemicals following exposure through a variety of routes, including pulmonary delivery, and develop countermeasures to mitigate the harmful effects of such exposures. Dr. Thorne is University of Iowa Distinguished Chair and Professor in the Department of Occupational and Environmental Health. His research interests are in environmental risk factors for inflammatory lung diseases and immunomodulation, the health impacts of climate-exacerbated disasters, and the toxicity of emerging and persistent environmental pollutants. Dr. Thorne has served the National Academy of Sciences, Engineering and Medicine on their Board on Environmental Studies and Toxicology and as Chair of the Committee on Toxicology and the Aircraft Cabin Air Quality Committee. From 2011 to 2017 and 2021-2025, he served on the U.S. Environmental Protection Agency’s Science Advisory Board (SAB) and served as Chair of the SAB from 2015-2017. Dr. Thorne was a member of the NIH National Advisory Environmental Health Sciences Council from 2003-2007. Dr. Thorne served as EHSRC Director from 2001-2020 and as Deputy Director from 1995-2000 and 2020-2026. He founded the EHSRC's Pulmonary Toxicology Facility (PTF) in 1994 and served as its Director until 2026. In addition to his leadership in the EHSRC and the PTF, Dr. Thorne was principal investigator of the AESOP Project (a community-based research study of PCB exposures) and leads research on the toxicity of inhaled PCB mixtures for the Iowa Superfund Research Program. He also is engaged in the development of medical countermeasures to treat respiratory injuries from chemical threat agent. Dr. Thorne is internationally recognized for his discoveries of the exacerbation of asthma and other respiratory diseases associated with domestic and occupational exposures to bioaerosols. His laboratory collaborates extensively providing exposure assessments for children’s environmental health studies. Dr. Kai Wang serves as the biostatistician for the Environmental Health Sciences Research Center (EHSRC) and is a Professor of Biostatistics at the University of Iowa. He has extensive expertise in statistical modeling and analysis of complex biomedical and environmental data, including high-dimensional omics data (genomics, sequencing, microarray, and imaging), clustered and correlated data (family studies, repeated measures, and longitudinal data), categorical outcomes, and time-to-event data. Dr. Wang directs the Data Management and Analysis Core of the Iowa Superfund Research Program, which focuses on polychlorinated biphenyls (PCBs) and other environmental pollutants. He is actively engaged in methodological research, with recent work emphasizing mediation analysis, Mendelian randomization, and spatial transcriptomics. Dr. Wang has authored more than 200 peer-reviewed publications spanning toxicology, environmental health sciences, biostatistics, and bioinformatics. He also serves on the editorial boards of Briefings in Bioinformatics and PLOS Genetics.
Professor of Occupational and Environmental Health; Center Director; Co-Leader, Water Quality Thematic Area (WQ-TA)
Hans-Joachim Lehmler, PhD
Research Assistant Professor, Occupational and Environmental Health; Director, Pulmonary Toxicology Facility
Andrea Adamcakova-Dodd, PhD
Associate Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine; Co-Leader, Inflammation and Innate Immunity Thematic Area (III-TA)
Josalyn Cho, MD
Clinical Professor, Internal Medicine - Pulmonary, Critical Care and Occupational Medicine; Director, Translational Research Support Core (TRSC); Co-Leader, Population Health Thematic Area (PH-TA)
Alejandro Comellas, MD
Professor of Civil and Environmental Engineering; Co-Leader, Water Quality Thematic Area (WQ-TA)
David M. Cwiertny, PhD
Professor, Pharmaceutical Sciences and Experimental Therapeutics; Co-Leader, Systemic and Redox Toxicology Thematic Area (SART-TA)
Jonathan A. Doorn, PhD
Professor and Richard Hichwa Chair, Radiology - Division of Cardiovascular and Thoracic Imaging; Co-Director/Imaging Director, Translational Research Support Core
Eric A. Hoffman, PhD
Clinical Professor of Occupational and Environmental Health; Center Deputy Director; Community Engagement Core Director; Co-Leader, Population Health Thematic Area (PH-TA)
Brandi Janssen, PhD
Professor of Animal Science, Iowa State University; Co-Leader, Systemic and Redox Toxicology Thematic Area
Aileen Keating, MS, PhD
Associate Professor of Occupational and Environmental Health; Director, Pilot Grant Program
Jong-Sung Kim, PhD
Professor of Pediatrics - Pulmonary Medicine; Co-Leader, Inflammation and Innate Immunity Thematic Area (III-TA)
Paul B. McCray, MD
Professor of Occupational and Environmental Health; Director, Exposure Science Facility (ESF)
Patrick T. O’Shaughnessy, PhD
Professor of Pharmaceutical Sciences; Senior Associate Vice President for Research; Co-Leader, Particle Science Thematic Area (PS-TA)
Aliasger Salem, PhD
University of Iowa Distinguished Chair and Professor, Occupational and Environmental Health; Center Associate Director; Co-Director, Pulmonary Toxicology Facility; Co-Leader, Particle Science Thematic Area (PS-TA)
Peter S. Thorne, PhD
Professor of Biostatistics; Biostatistician, Translational Research Support Core (TRSC)
Kai Wang, PhD
.team-manager-free-main-area-1863 { display: block; overflow: hidden; } .team-manager-free-main-area-1863 .team-manager-free-container{ display: -webkit-box; display: -ms-flexbox; display: flex; -ms-flex-wrap: wrap; flex-wrap: wrap; } .team-manager-free-main-area-1863 .team-manager-free-items { background: #f8f8f8; text-align:default; } .team-manager-free-main-area-1863 .team-manager-free-items i{ padding-right:5px; } .team-manager-free-main-area-1863 .team-manager-free-items-thumb a { border: medium none; border-radius: 0; box-shadow: none; outline: medium none; text-decoration: none; } .team-manager-free-main-area-1863 .team-manager-free-items-description{ padding:15px; } .team-manager-free-main-area-1863 .team-manager-free-items-thumb { position: relative; overflow: hidden; line-height: 0; } .team-manager-free-main-area-1863 .team-manager-free-items-thumb img{ width: 100%; height: auto; transition: all 0.3s ease-in-out; } /* Zoom In */ .team-manager-free-main-area-1863 .tmf-member-title, .team-manager-free-main-area-1863 .tmf-member-title a{ margin: 0px; overflow: hidden; color: #007acc; font-size: 15px; text-transform: unset; outline: medium none; text-decoration: none; box-shadow: none; } .team-manager-free-main-area-1863 .tmf-member-title a:hover{ color:#333333; } .team-manager-free-main-area-1863 .tmf-designation{ display:block; color: #333333; font-size: 12px; font-style: ; text-transform: unset; margin-bottom: 10px; }
EHSRC Role: Assistant Director, Community Engagement Core Jackie oversees a variety of programs such as the Community Engagement and Research Training Program for faculty and staff, the CERT Fellowship, the Stakeholder Advisory Board, the regional Environmental Health Needs Assessment, and environmental health translational products such as the Iowa Climate Podcasts and environmental contaminant fact sheets. Ms. Curnick holds degrees from the University of Florida (2018, Masters of Sustainable Development Practice) and Florida State University (2014, Bachelors of Science in Social Sciences). Ms. Curnick brings training in global development and experiences, such as a Fulbright grant in South Africa, summer project in Rwanda, and a graduate certificate in African Studies. Her graduate work focused on environmental injustice experienced by Native Alaskan communities in the Bering Sea. Rose Phillips joined the EHSRC in 2024. As the Center Coordinator, Phillips manages the Center’s daily affairs, providing support for grant renewals, coordinating the Pilot Grant Program and Career Enhancement Program, assisting researchers with Human Subjects reviews, facilitating meetings, and tracking new opportunities in environmental health sciences research. Phillips holds a B.A. in Environmental Studies from Mount Holyoke College and an M.S. in Urban and Regional Planning from the University of Iowa. Prior to joining the EHSRC, Phillips conducted research and grant management related to affordable housing in the public and nonprofit sectors.
Assistant Director, Community Engagement Core
Jackie Curnick, MDP
Center Coordinator
Rose Phillips, MS
Center Administrator
Mindy Sickels-Sterbenz, BBA
.team-manager-free-main-area-2222 { display: block; overflow: hidden; } .team-manager-free-main-area-2222 .team-manager-free-container{ display: -webkit-box; display: -ms-flexbox; display: flex; -ms-flex-wrap: wrap; flex-wrap: wrap; } .team-manager-free-main-area-2222 .team-manager-free-items { background: #ffffff; text-align:default; } .team-manager-free-main-area-2222 .team-manager-free-items i{ padding-right:5px; } .team-manager-free-main-area-2222 .team-manager-free-items-thumb a { border: medium none; border-radius: 0; box-shadow: none; outline: medium none; text-decoration: none; } .team-manager-free-main-area-2222 .team-manager-free-items-description{ padding:15px; } .team-manager-free-main-area-2222 .team-manager-free-items-thumb { position: relative; overflow: hidden; line-height: 0; } .team-manager-free-main-area-2222 .team-manager-free-items-thumb img{ width: 100%; height: auto; transition: all 0.3s ease-in-out; } /* Zoom In */ .team-manager-free-main-area-2222 .tmf-member-title, .team-manager-free-main-area-2222 .tmf-member-title a{ margin: 0px; overflow: hidden; color: #007acc; font-size: 15px; text-transform: unset; outline: medium none; text-decoration: none; box-shadow: none; } .team-manager-free-main-area-2222 .tmf-member-title a:hover{ color:#333333; } .team-manager-free-main-area-2222 .tmf-designation{ display:block; color: #333333; font-size: 12px; font-style: normal; text-transform: unset; margin-bottom: 10px; }
Pronouns: he/him/his Dr. Lehmler is a Professor at the College of Public Health and has served as the EHSRC Director since 2020. Prior to that time, he was the EHSRC Deputy Director. Dr. Lehmler is an experienced environmental health scientist and highly qualified research grant administrator. In addition to his role as EHSRC Director, Dr. Lehmler is among the leadership team of the Exposure Science Facility and serves as the director of the Career Enhancement Program. He leads a joint seminar series that regularly brings together faculty, staff, and students of the EHSRC and the Interdisciplinary Graduate Program in Human Toxicology. Additionally, he oversees the activities of the Water Quality thematic area together with Dr. David Cwiertny. His NIEHS-funded research employs novel animal models, including germ-free mice and transgenic animals, to characterize how the metabolism of chemical hazards, such as polychlorinated biphenyls (PCBs), affects neurotoxic outcomes across the lifespan. These studies bring together investigators from the UC Davis Environmental Health Sciences Core Center, the Center for Exposures, Diseases, Genomics, and Environment (EDGE) at the University of Washington, and the Southwest Environmental Health Sciences Center (SWEHSC) at the University of Arizona. Dr. Lehmler also serves as Deputy Director of the Iowa Superfund Research Program under the direction of Dr. Keri Hornbuckle. Under this program, Dr. Lehmler leads a Research Project investigating the neurotoxicity of inhaled PCBs in adolescents. This Research Project brings together several EHSRC researchers, including Hanna Stevens and Jonathan Doorn, to study how adolescent exposure to airborne PCBs is mechanistically linked to altered neurodevelopmental outcomes through mitochondrial dysfunction in astrocytes. Dr. Lehmler also leads the Synthesis Core of the Iowa Superfund Research Program and is a member of the leadership team of the Analytical Core. Dr. Ashida's training and expertise include aging and gerontology, dementia caregiving, health behavior interventions, social network and support, community-engaged research, implementation research, and workforce development. Her research focuses on identifying social factors that facilitate or deter health, and to develop social network interventions to promote healthy aging in place. Currently, she is a PI on the Disaster PrepWise study, which tests the impact of Disaster PrepWise intervention on caregiver outcomes such as resilience and stress (NIA R01). She is also active in workforce training, serving as the Director of the Public Health Practice and Workforce Development Core at the Institute for Public Health Practice, Research, and Policy; Co-Director of the Midwestern Public Health Training Center (MPHTC); and Co-Director of the Iowa Public Health AmeriCorps Program. Dr. Ashida works closely with local, state, and regional partners including health departments, emergency management agencies, Area Agencies on Aging, and other non-profit organizations to develop intervention delivery infrastructure to implement and sustain public health programs in community. Dr. Adamcakova-Dodd serves as Director of the Pulmonary Toxicology Facility (PTF) within the Environmental Health Sciences Research Center (EHSRC). She leads interdisciplinary research focused on adverse outcomes following inhaled environmental and occupational exposures. Her earlier research focused on the epidemiology of allergic diseases among children in relation to environmental factors including placental contamination by heavy metals or polychlorinated biphenyls (PCBs). Dr. Adamcakova-Dodd joined the PTF in 2002 and has since led and collaborated on studies evaluating the toxicity of a wide range of inhaled agents, including particulate aerosols (metal and metal oxide nanoparticles and carbon nanotubes), vapors (PCBs), metalworking fluids, endotoxin, biological aerosols containing pathogenic microorganisms, and toxic gases (sulfur dioxide, chlorine, and phosphine). She has extensive experience designing and conducting toxicological studies using both in vitro models, including air–liquid interface systems, and in vivo models with the assessment of a broad range of toxicological, biological, and functional endpoints. Her research experience includes the development and application of diverse models of pulmonary injury and disease, including inflammation induced by endotoxin or particulate matter, allergic asthma induced by house dust mite allergen, hypersensitivity pneumonitis associated with metalworking fluids, pulmonary fibrosis induced by bleomycin or crystalline silica, and acute lung injury resulting from exposure to toxic gases. Recent areas of research emphasis include the inhalation toxicology of emerging contaminants such as micro- and nanoplastics, the development of medical countermeasures against chemical threat agents, and the elucidation of extracellular vesicle-mediated mechanisms involved in the initiation, progression, and resolution or persistence of pulmonary inflammation. A particular focus of her research is identifying specific miRNAs involved in the resolution of pulmonary inflammation and evaluating their potential as therapeutic agents following exposure to toxic inhaled aerosols or gases. Through the PTF, she provides scientific and strategic leadership, develops research capabilities, facilitates multidisciplinary collaborations, and supports investigators in the design, execution, and interpretation of pulmonary toxicology studies. She is also committed to mentoring graduate students, postdoctoral fellows, and research staff. Dr. Andres Martinez is an Associate Research Engineer at IIHR—Hydroscience & Engineering and an Adjunct Assistant Professor of Civil and Environmental Engineering. He has expertise in the areas of field sampling, development of analytical method and analysis of hydrophobic organic compounds in complex environmental matrices, environmental modeling, and data analysis. Distribution, transport, and fate of polychlorinated biphenyls (PCBs) in air, water and sediment/soil have been his main areas of interest. Dr. Blount is a physician scientist studying air pollution health effects both in the US and globally. His current research focuses on the immunologic mechanisms through which air pollutants increase risk for tuberculosis (TB) and other pulmonary infections. He has substantial research, teaching, and clinical experience in East Africa and Southeast Asia. Prior to fellowship, he led an international health education program in Kenya, teaching Kenyan and American students, residents, and fellows as well as caring for HIV and TB patients. Over the past 4 years, Dr. Blount has been collaborating with the Vietnam National Tuberculosis Program and is currently developing air pollution monitoring and immunology lab infrastructure for a K23 project to elucidate the immunologic and clinical effects of air pollution on childhood tuberculosis. Publications: Dr. Burnett is a highly trained Associate Professor in the Department of Radiation Oncology. Dr. Burnett studies the role of inflammation and oxidative stress on the anti-tumor efficacy of head and neck cancer therapy. The long-term goal of her work is to design novel and effective strategies to increase survival outcomes and quality of life in all head and neck squamous cell carcinoma (HNSCC) patients. The high impact of her work to the field of cancer therapeutics and redox biology is reflected by her numerous publications in high impact peer-reviewed journals. Some of the highlights include: 1) the discovery of NADPH oxidase (NOX)- mediated oxidative stress as a novel mechanism for EGFR inhibitors, 2) the discovery that immune response and interleukin-1 signaling are strong predictors of tumor response to drug therapy, and 3) the recent discovery that TLR9 activation using a virus like particle may enhance tumor response to anti-PD1 in an HPV+ mouse model. Her current work seeks to understand how manipulating certain members of the Toll/Interleukin-1 receptor (TIR) family could enhance and/or predict durable tumor responses to both radiotherapy, EGFR-targeted therapy, and immunotherapy. This work has received remarkable attention and interest from clinicians within the University of Iowa with a goal of pushing these studies from the bench to the bedside in the HNSCC setting. The primary research focus of the Chatterjee lab is to understand the molecular mechanisms underlying long-term memory loss in Alzheimer’s disease and related dementia (ADRD). His lab uses multifaceted state-of-the-art approaches such as single-nuclei (RNA+ATAC) multi-omics, spatial transcriptomics, native chromatin enrichment studies, proximity labeling, pharmacology, behavioral techniques, and AAV-based manipulation of transcription in the mouse brain. Using these tools, his goal is to understand the molecular mechanisms that go awry in neurodegeneration. His lab also employs humanized mouse models of ADRD, susceptible to amyloid or tauopathy to study the polychlorinated biphenyls (PCBs) induced neurotoxicity leading towards the risk for dementia (in collaboration with Dr. Hans-Joachim Lehmler). His research on environmental health sciences focuses on assessing how human-relevant PCB mixtures alter the development and progression of ADRD-like phenotypes in animal models of ADRD. Selected Publications: Dr. Cho is a pulmonologist and Co-Leader of the EHSRC's Inflammation and Innate Immunity Thematic Area (III-TA). She leads a basic and translational immunology research program focused on understanding the pathogenesis of inflammatory lung diseases. Using both mouse and human models of disease, her laboratory investigates the contributions of innate and adaptive immune responses to allergic asthma, smoking- and vaping-related diseases, and respiratory viral infection. Selected Publications: Dr. Comellas is a Clinical Professor in the Division of Pulmonary, Critical Care, and Occupational Medicine; Director of Clinical Research Support for the Institute for Clinical and Translational Science (ICTS); and Director of the Translational Research Support Core for the Environmental Health Sciences Research Center (EHSRC) at the University of Iowa . His research integrates mechanistic, clinical, and imaging-based approaches to understand lung injury and chronic respiratory disease. A major focus of his current work is the use of quantitative CT, advanced image analysis, and artificial intelligence to characterize small-airways disease, emphysema, vascular abnormalities, and extrapulmonary manifestations of COPD and post-acute COVID-19. Through leadership and collaboration in large multicenter studies, including SPIROMICS and COPDGene, Dr. Comellas aims to identify imaging and biologic phenotypes that improve early detection, risk stratification, and personalized treatment of smoking-related and environmentally mediated lung disease. The Comeron Lab is interested in understanding the causes and consequences of variation across genomes, among individuals of the same species, and between species. His team pays particular attention to recombination as a fundamental parameter in the evolution of genes, genomes and, ultimately, species. They study the molecular causes and evolutionary consequences of recombination variation. To this end they apply an interdisciplinary approach using population genetics, bioinformatics, computer simulations, traditional genetics, and next-generation sequencing techniques to study genomes and transcriptomes. They take full advantage of the unparalleled genetic and genomic tools available in the Drosophila model system. Dr. Cwiertny’s research program broadly focuses on pollutant fate in natural and engineered aquatic systems, relying on complementary tools from engineering, chemistry and materials science. He has specific expertise related to the (i) environmental fate and risk assessment of emerging pollutant classes, and (ii) development of (nano)material-based technologies for resource sustainability. In particular, his work often focuses on issues at the intersection of environmental quality with public health and public policy. In October of 2017, Dr. Cwiertny was appointed Director for the Center of Health Effects of Environmental Contamination (CHEEC), a state-sponsored research center focused on improving the environmental quality and public health of Iowans. At the EHSRC, Dr. Cwiertny co-leads the Water Quality Thematic Area (WQ-TA), coordinating activities among EHSRC members across three colleges (Public Health, Engineering, and Liberal Arts and Science) with research expertise in water quality and health impacts associated with water contamination. Between 2015 and 2023, Dr. Cwiertny served as the Director of the Environmental Policy Research Program at the UI Public Policy Center (UI PPC). In 2016-2017, he served as an American Association for the Advancement of Science (AAAS) Congressional Fellow, working as minority staff for the House of Representatives Committee on Energy and Commerce and its subcommittees on Energy and Environment. Dr. Dalton's research broadly explores One Health microbial dynamics among humans, animals, and their shared environment, and how microbial communities relate to human health outcomes. She employs multidisciplinary techniques from epidemiology, environmental science, microbiology, and ethnography to explore the dynamic balance of detrimental and positive impacts on health from human-animal-environmental interactions, with an emphasis on infectious and respiratory conditions. Dr. Donovan's laboratory has been actively investigating the absorption of compounds via the nasal cavity for over 20 years. Current research is focused on identifying the mechanisms controlling the preferential disposition of materials absorbed across the nasal mucosa and transferred to the CNS. The lab is examining the ability of uptake and efflux transporters, along with endocytotic processes to transfer materials from the nasal cavity to the brain while bypassing the blood-brain barrier. With the increasing interest in the ability of inhaled environmental contaminants reaching the brain via the nasal/olfactory pathways,Dr. Donovan's lab has initiated new investigations in the uptake of nanoparticles and other environmental toxins into the brain. Selected Publications: Dr. Doorn’s research program is focused on elucidating mechanisms of neurotoxicity relevant to neurodegenerative disease with particular attention to the role of environmental contaminants. Of particular interest is the role of environmental organochlorines, e.g., polychlorinated biphenyls (PCBs), dieldrin, and organophosphates in generating toxic conditions in vitro/in vivo that adversely modulate dopaminergic and glial cells, work highly relevant to neurodegenerative and neurodevelopmental conditions. Recent work examined the role of the organochlorine dieldrin in stressing dopaminergic cells to produce elevated levels of a toxic dopamne metabolite (i.e., 3,4-dihydroxyphenylacetaldehyde). In collaboration with the Iowa Superfund Research Program and Drs. Hans Lehmler and Hanna Stevens, Dr. Doorn has shown that PCBs and their human relevant metabolites target astrocyte mitochondria yielding a bioenergetic crisis, in particular a specific congener (PCB52 and its metabolites). In addition, he is interested in the role of natural product analogs in eliciting a protective response and collaborating with Drs. David Martin and Marie Gaine on a drug discovery project that focuses on the NRF2-KEAP1 system and neuroprotection against agents such as organophosphates. Pronouns: she/her/hers Dr. Eggers directs the Microbial Exposomics Lab, which investigates interactions between the human microbiome and environmental exposures in chronic disease risk across the lifespan from an epidemiologic perspective. Through multidisciplinary approaches integrating microbiome science, exposure assessment, and molecular epidemiology, her work aims to identify biological pathways that can inform prevention strategies for environmentally driven adverse health outcomes, including maternal and child health, neurobehavioral functioning, and cancer. The Fain lab is dedicated to developing functional imaging of the lungs using magnetic resonance imaging (MRI). Multiple methods are in development and are actively in use for clinical research. Most prominently, ultra-short time to echo (UTE) pulmonary MRI and hyperpolarized xenon gas MRI are actively being used to study long COVID, interstitial lung disease, cystic fibrosis, lung transplant rejection and asthma. Our work has applications in understanding of environmental population health given our ability to measure ventilation and gas exchange regionally with sufficient sensitivity to detect subclinical changes not detected by conventional pulmonary function tests. The MRI techniques developed in the Fain lab are furthermore complementary to quantitative CT methods by providing functional information without using ionizing radiation. Selected Publications: Dr. Fethke serves as Director of the Great Plains Center for Agricultural Health (GPCAH), one of 12 Centers for Agricultural Safety and Health supported across the nation by the National Institute for Occupational Safety and Health (NIOSH). GPCAH serves a 9-state region in the Midwest and is nationally recognized for its programs of research, intervention, translation, education, and outreach to prevent occupational injury and illness among agricultural workers and their families. As GPCAH Director, Dr. Fethke advances exposure-related research in agricultural settings and translates findings into accessible preventive interventions to reduce environmental health burdens. The Flunker lab seeks to characterize, quantify, and refine spatiotemporal estimates of environmental and occupational exposures and associated adverse health outcomes among at-risk populations. Research areas of interest include exposures driven by extreme weather events and natural disasters, namely heat and wildfire smoke, respiratory disease, heat-related illness, cancer, biomarkers of exposure, and exposure-outcome statistical modeling. Dr. Forbes is an inorganic chemist who investigates the aqueous speciation of actinide elements and self-assembly of coordination compounds. Her group focuses on the speciation of thorium, uranium and neptunium in aqueous systems using a combination of diffraction and spectroscopic techniques. They collaborate with faculty interested in water quality issues related to naturally occurring radioactive materials and legacy nuclear waste. This includes efforts to test private wells for radium in rural Iowa and supporting efforts to understand uranium mobility in groundwater systems in New Mexico. Dr. Forbes also directs the University of Iowa's Materials Analysis, Testing, and Fabrication (MATFab) Facility, which offers state-of-the-art characterization, fabrication, and materials analysis capabilities to researchers across the UI campus and beyond. Selected Publications: The Gaine Lab is dedicated to understanding the role of genetics and epigenetics in the development and treatment of psychiatric disorders, and how environmental factors can influence this. Projects primarily focus on DNA methylation and methylation quantitative trait loci (meQTLs) as well as novel biomarkers such as extracellular vesicles and cell-free DNA, which hold promise for non-invasive diagnostics and precision medicine approaches. Dr. Gaine's research prioritizes high-risk populations, including pregnant people, individuals with bipolar disorder, and individuals exposed to pesticides. By integrating cutting-edge sequencing techniques and interdisciplinary approaches using human samples and mouse models, her group strives to advance knowledge and develop tools that can improve outcomes for individuals affected by these psychiatric disorders. Selected Publications: Dr. Gerke's current research is directed at evaluating the role of environmental exposures in the development of interstitial lung diseases such as pulmonary fibrosis and sarcoidosis. Selected Publications: 1. Hagner MD, Miller A, De la Serna S, Arakkal A, Cavanaugh J, Pezzulo A, Hamzeh N, Polgreen P, Gerke A. The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis. Sarcoidosis Vasc Diffuse Lung Dis. 2026 Jun 22;43(2):18607. doi:10.36141/svdld.2026.18607. PMID:42329014; PMCID:PMC13359006. 2. Wells AU, Lower EE, Baughman RP, Culver DA, Judson MA, Bonham CA, Gerke AK, et al. A paradigm shift in corticosteroid therapy for sarcoidosis. Lancet Respir Med. 2026 Apr;14(4):363-374. doi:10.1016/S2213-2600(25)00338-8. PMID:41207318; PMCID:PMC13397509. 3. Stapleton EM, Metwali N, Shlossman M, Wendt L, Pezzulo AA, Hamzeh NY, Comellas AP, Thorne PS, Gerke AK. Residential fungal β-(1,3)-D-glucan exposure is associated with decreased pulmonary function in fibrotic pulmonary sarcoidosis. Res Sq. 2024 Oct 22:rs.3.rs-5220174. PMID:39502781; PMCID:PMC11537350. 4. Wang S, Laageide L, Phan V, Rosenbach M, Gerke AK, Wanat KA. Use of registry surveys in cutaneous sarcoidosis. J Am Acad Dermatol. 2024 Jun;90(6):1294-1296. doi:10.1016/j.jaad.2024.02.023. PMID:38395226. 5. Gerke AK. Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis. J Clin Med. 2024 Jan 27;13(3):738. doi:10.3390/jcm13030738. PMID:38337432; PMCID:PMC10856377. 6. Chung H, Hanken K, Gerke AK, Lund BC. Montelukast and risk for antidepressant treatment failure. J Psychosom Res. 2023 Jan;164:111075. doi:10.1016/j.jpsychores.2022.111075. PMID:36368225. 7. Fox CW, Khaw CL, Gerke AK, Lund BC. Montelukast and neuropsychiatric events. J Asthma. 2022 Dec;59(12):2360-2366. doi:10.1080/02770903.2021.2018705. PMID:34979844. 8. Simmering J, Stapleton EM, Polgreen PM, Kuntz J, Gerke AK. Patterns of medication use and imaging following initial diagnosis of sarcoidosis. Respir Med. 2021 Nov-Dec;189:106622. PMID:34600163; PMCID:PMC10918686. 9. Zhou Y, Gerke AK, Lower EE, et al. The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. Respir Med. 2021 Oct;187:106564. PMID:34391118; PMCID:PMC9999732. 10. Priya S, Aggarwal T, Ward C, Bathla G, Jacob M, Gerke A, Hoffman EA, Nagpal P. Radiomics side experiments and DAFIT approach in identifying pulmonary hypertension using Cardiac MRI derived radiomics based machine learning models. Sci Rep. 2021 Jun 16;11(1):12686. PMID:34135418; PMCID:PMC8209219. 11. Priya S, Aggarwal T, Ward C, Bathla G, Jacob M, Gerke A, Hoffman EA, Nagpal P. Radiomics Detection of Pulmonary Hypertension via Texture-Based Assessments of Cardiac MRI. J Clin Med. 2021 Apr 28;10(9):1921. PMID:33925262; PMCID:PMC8125238. 12. Miller AC, Arakkal AT, Koeneman S, Cavanaugh JE, Gerke AK, Hornick DB, Polgreen PM. Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis. BMJ Open. 2021 Feb 18;11(2):e045605. PMID:33602715; PMCID:PMC7896623. 13. Philibert R, Mills JA, Long JD, Salisbury SE, Comellas A, Gerke A, Dawes K, Vander Weg M, Hoffman EA. The Reversion of cg05575921 Methylation in Smoking Cessation. Genes (Basel). 2020;11(12):1415. PMID:33260961; PMCID:PMC7760261. 14. Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol. 2020 Nov 19;11:545413. PMID:33329511; PMCID:PMC7732561. 15. Vargas Buonfiglio LG, Vanegas Calderon OG, Cano M, Simmering JE, Polgreen PM, Zabner J, Gerke AK, Comellas AP. Seasonal Antimicrobial Activity of the Airway. Nutrients. 2020;12(9):2602. PMID:32867053; PMCID:PMC7551279. 16. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and Detection of Sarcoidosis. Am J Respir Crit Care Med. 2020;201(8):e26-e51. PMID:32293205; PMCID:PMC7159433. 17. Harper LJ, Gerke AK, Wang XF, et al. Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis. Am J Respir Crit Care Med. 2020;201(8):955-964. PMID:31825646; PMCID:PMC7924656. Dr. Eric A. Hoffman, Ph.D. received his Ph.D. in Physiology from the University of Minnesota / Mayo Graduate School of Medicine in 1981 and remained on staff at the Mayo Clinic where he was a member of the team which Developed the Dynamic Spatial Reconstructor (DSR), the earliest volumetric X-Ray computed tomographic scanner. He currently is the director of the Advanced Pulmonary Physiomics Laboratory (APPIL) at the University of Iowa. Throughout his career, Dr. Hoffman has used advanced imaging methodologies to study basic respiratory physiology centered largely on mechanisms of ventilation and perfusion heterogeneity and regional lung mechanics. In the late 1970s, volumetric computed tomography was used to provide a first look at regional lung mechanics in the never invaded negative pressure environment of the intact thorax. Hoffman’s contributions have served to illuminate many underlying relationships in COPD, Asthma and environmental lung diseases. Recent work has led to the investigation of vascular dysfunction in the etiology of emphysema based upon novel uses of dual energy multidetector row CT (DECT). A key contribution of Dr. Hoffman’s work lies in the continued efforts to provide analysis tools, coordination, quality control and image analysis to support NIH sponsored multi-center studies (NETT, MESA Lung, SPIROMICS, SARP, PrecISE, etc.) whereby imaging of the lung serves to explore novel phenotypes or to provide outcomes measures related to interventions. The APPIL laboratory includes a research dedicated, state-of-the-art photon-counting CT scanner (Siemens Naeotom Alpha) supported, in part, through an NIH high-end shared instrumentation grant. Pronouns: she/her/hers Keri Hornbuckle is a Professor in Civil and Environmental Engineering and University of Iowa Distinguished Chair. She also serves as Director of the Iowa Superfund Research Program (ISRP), a P42 multi-project interdisciplinary research center funded by the National Institute for Environmental Health Sciences (NIEHS/NIH) and titled “Sources, Exposures, Toxicities, and Remediation of Airborne PCBs.” She has served on the Science Advisory Board of the International Joint Commission; the U.S. EPA Environmental Laboratory Advisory Board (ELAB); and the Advisory Boards of Superfund Research Program Centers in Texas and New Mexico. Janssen is a Clinical Professor in the Department of Occupational and Environmental Health. Trained as a cultural anthropologist, she has extensive experience in qualitative and ethnographic methods and community engaged research in rural spaces, particularly focusing on agriculture, food systems, and environmental health. Janssen transitioned to the role of Deputy Director in 2025. She has served as Director of the EHSRC Community Engagement Core (CEC) since 2018 and as Director of Undergraduate Programs in the College of Public Health since 2022. As CEC Director, Janssen led a regional environmental health needs assessment, which collected data about environmental health concerns, trusted information sources, and disaster preparedness across Iowa, Nebraska, Kansas and Missouri. She oversees the development of environmental health resources for rural communities and multi-media products, including the Iowa Environmental Health Podcast. In addition, Janssen is the lead PI of Central Midwest COLEARN, a NOAA RISA team (NA23OAR4310629). In this role, she work with rural residents across Iowa, Nebraska, Kansas, and Missouri identifying community-based needs related to extreme weather preparedness to deliver appropriate programming. Overall, Janssen's integrative approach emphasizes a holistic and community-based perspective that takes into account the complex cultural interactions that underlie rural environmental challenges. Dr. Craig L. Just is a Professor of Civil and Environmental Engineering at the University of Iowa, where his research integrates environmental biotechnology, analytical chemistry, artificial intelligence, and process systems engineering to advance sustainable water and resource recovery. His work focuses on developing intelligent monitoring and decision-support tools for biological treatment processes, with particular emphasis on anaerobic digestion, co-digestion, nutrient removal, and wastewater lagoon intensification. Dr. Just leads interdisciplinary research on the application of machine learning, diffuse reflectance spectroscopy, and deployable sensor technologies to provide real-time insight into biological treatment performance. His group develops predictive models and digital tools that enable wastewater utilities, agricultural producers, and renewable energy facilities to optimize operations, improve process resilience, and maximize resource recovery. Current projects include AI-enabled monitoring of anaerobic digesters, rapid characterization of organic wastes, methane emissions from wastewater treatment systems, algal-based nutrient recovery, and innovative technologies for ammonia removal in municipal lagoons. Dr. Keating’s research group studies phenotypic outcomes and mechanisms of action induced by environmental ovotoxicant exposures. In addition, they have discovered that alterations to physiological status (heat stress, obesity) can be additive to the negative effects of ovotoxic chemical exposures. The ultimate goal of her studies is to identify and develop intervention strategies to ameliorate the negative reproductive impacts of ovotoxicant exposure and improve female health. Jong Sung Kim is an Associate Professor of Occupational & Environmental Health in the University of Iowa College of Public Health. He serves as Director of the UI Human Toxicology Program (HTP) and the EHSRC's Pilot Grant Program. His interdisciplinary research integrates environmental chemistry, toxicology, exposure science, and human biomonitoring to understand the health effects of environmental and occupational exposures. Kim's research focuses on inhalation toxicology, metals and metallomics, and emerging contaminants, including tire-wear associated particles and chemicals, nanoparticles and micro- and nanoplastics. His laboratory combines advanced analytical approaches, including mass spectrometry, metallomics, and chemical exposome profiling, with inhalation toxicology using in vitro air-liquid interface (ALI) models and in vivo inhalation studies to characterize exposure, biological responses, and mechanisms of toxicity. His work has advanced ALI approaches for investigating airborne particles and particle-contaminant interactions and contributed to the development and application of toenail biomarkers for assessing cumulative exposure to metals in population-based studies. More recently, his research integrates metallomics with untargeted high-resolution mass spectrometry to identify biomarkers of environmental exposure, susceptibility, and disease risk. Kim collaborates broadly across epidemiology, chemistry, engineering, exposure science, and clinical disciplines to address emerging environmental health challenges. Through his leadership of the EHSRC Pilot Grant Program, he fosters interdisciplinary research and supports early-stage investigators in developing innovative environmental health research into competitive, independently funded programs. He is also deeply committed to graduate education and mentorship through his leadership of the Human Toxicology Program. Dr. Klesney-Tait's research focuses on the role of neutrophils in the regulation of inflammation. Her laboratory utilizes animal models of pneumonia, sepsis and reperfusion to study neutrophil function. In particular, they are exploring the Triggering Receptor Expressed on Myeloid cells 1 (TREM-1), an innate immune receptor expressed on neutrophils that functions as an amplifier of proinflammatory signaling. The Klingelhutz Lab's research involves studies on how environmental and microbial factors contribute to the development of disease, including metabolic syndrome. Their expertise in cell immortalization and cell culture techniques has allowed us develop 3D cell culture models that recapitulate human tissue for our research. Dr. Klingelhutz is particularly interested in the role that fat tissue plays in infection and disease. Current research focuses on how early-life exposure to persistent environmental toxicants, namely, polychlorinated biphenyls (PCBs), alters fat function, leading to inflammation, insulin resistance, and steatosis. Non-point source pollutants are the leading cause of water quality degradation. Dr. LeFevre's research focuses on the biotransformation mechanisms (e.g., plants, bacteria, fungi) of trace organic contaminants to create natural systems-based treatment technologies that improve water quality. Understanding of pollutant transformation processes facilitates low-energy engineered natural treatment systems that are reliable, robust, and resilient. Examples include understanding the fate and transformation of contaminants in stormwater and the use of bioretention systems to capture and degrade pollutants. Additionally, the LeFevre Lab studies pesticide fate and transport in urban and agricultural systems, and fate/impacts of emerging organic contaminants in recycled water in ecosystems and when used for crop irrigation. Dr. Lin’s research group has developed CT-based, multiscale, subject-specific computational fluid and particle dynamics (CFPD) models of the human lungs, as well as automated airway modeling and mesh generation, thermodynamic and hygroscopic particle models, airway surface liquid models, and mass-preserving image-registration methods. More recently, his group has developed multiscale imaging-based clustering and deep learning approaches to connect individual- and population-level lung phenotypes and identify tissue-pattern clusters and latent traits from CT images in diverse populations, including subjects with COPD and asthma, individuals exposed to humidifier disinfectants, and post-COVID-19 subjects. His group has also developed CFPD–PBPK/PD models for healthy and asthmatic subjects. Dr. Lynch's major research interest center around population-based research involving a cancer surveillance program (Iowa Cancer Registry) and cancer epidemiology and surveillance, cancer pathology, and environmental epidemiology. Selected Publications: 1. Reiner AS, Malone KE, Lynch CF, Mellemkjær L, Knight JA, John EM, Liang X, Woods M; WECARE Study Collaborative Group; Bernstein JL. Risk factors for estrogen receptor subtype-specific contralateral breast cancer in women under age 55 years. International Journal of Cancer 2026 Aug 7. Online ahead of print. PMID42563563 A major focus of the Mangalam Lab's work is determining how environmental contaminants alter the gut microbiome and thereby influence host immune responses. In collaboration with Dr. Hans-Joachim Lehmler, the Mangalam Lab has used glyphosate as a model environmental toxicant. Glyphosate is particularly interesting because its primary biochemical target, the shikimate pathway, is absent in mammalian cells but present in many microbes including gut bacteria. Dr. Mangalam and collaborators demonstrated that chronic low-dose glyphosate exposure disrupts gut microbial communities, including depletion of beneficial bacteria such as Lactobacillus and Bifidobacterium, and is accompanied by increased colonic IL-17A–producing CD4 T cells and elevated lipocalin-2, a marker of intestinal inflammation. These findings support the concept that the microbiome can serve as an important intermediary through which environmental exposures alter immune homeostasis and contribute to chronic inflammatory conditions. The Mangalam Lab's environmental health research builds on a broader program examining how microbiome dysbiosis contributes to immune-mediated disease. Dr. Mangalam and colleagues were among the first groups in the United States to demonstrate that people with multiple sclerosis (MS) harbor a distinct gut microbiome, characterized by depletion of potentially beneficial bacteria and enrichment of inflammation-associated taxa. Subsequent studies from our laboratory showed that bacteria involved in the metabolism of dietary phytoestrogens, including Prevotella, Parabacteroides, and Adlercreutzia, are depleted in MS. Using mechanistic animal models, the Mangalam Lab demonstrated that restoration of these bacteria and their dietary substrates can promote regulatory immune responses and suppress neuroinflammation. The Mangalam Lab also identified human-derived beneficial bacteria, including Prevotella histicola, that can induce regulatory T cells and ameliorate disease in experimental models of MS. Together, these studies support two interconnected themes in our laboratory: (1) defining how environmental exposures, diet, and host factors disrupt beneficial microbial communities and promote inflammatory states, and (2) identifying beneficial microbes, microbial functions, and metabolic pathways that can be leveraged to restore immune homeostasis. Ongoing work is examining how glyphosate-induced microbiome disruption may contribute to chronic inflammation, adipose tissue inflammation, obesity, and metabolic syndrome, and whether microbiome-directed interventions can mitigate these effects. The Mangalam Lab's long-term goal is to define the microbiome-mediated mechanisms that connect environmental exposures to disease and use this knowledge to develop microbial biomarkers, targeted microbiome interventions, and strategies that preserve or restore beneficial microbial functions without broadly disrupting the microbial ecosystem. Dr. Mattes possesses expertise in the areas of environmental microbiology, environmental biotechnology, bioremediation and environmental engineering. His current research interests include application of molecular microbial ecology techniques to understand the roles of microorganisms in biodegradation of hazardous compounds in environment (including chlorinated ethene (CEs) and polychlorinated biphenyls (PCBs)). He is also interested in the evolution of biodegradation pathways and microbial network interactions to effect removal of pollutants from groundwater, soils, and sediments. Dr. McCray has a long-standing interest in the pathogenesis and treatment of cystic fibrosis. His laboratory has two main areas of investigation: 1) pulmonary host defense, and 2) gene transfer for the treatment of inherited diseases. Work in the lab is supported by the NIH and the Cystic Fibrosis Foundation. Dr. O'Shaughnessy directs the EHSRC's Exposure Science Facility (ESF). Dr. O’Shaughnessy was educated as an environmental engineer with expertise in the simulation of the dispersion of contaminants near a pollution source, exposure assessment methods, as well as the assessment of aerosol and gas sensors. As the ESF director, he has counseled multiple Center investigators and pilot grant awardees concerning proper assessment methods for aerosol and gas exposures and has gained substantial knowledge of the related projects and outcomes as a result. Dr. O’Shaughnessy has a long-standing reputation in the field of industrial hygiene as an expert in aerosol exposure assessment, the evaluation of sampling devices for nanoparticle detection, the factors that affect the efficacy of respirators, and the use of air dispersion modeling to investigate the health effect of ambient air pollutants on nearby populations. Recent studies have focused on the plumes of dust emitted by passing cars traveling on rural gravel roads and their potential to aggravate pulmonary conditions among nearby residents. Dr. Pan's research focuses on understanding the risks and health impacts of bioaerosols and other aerosol pollutants, and developing surveillance tools and non-pharmaceutical interventions to protect respiratory health. Dr. Pan serves as the Bioaerosol Exposure Specialist for the Exposure Science Facility (ESF). A constant theme of Dr. Parker’s research is the design of community health promotion interventions that address major social determinants of health and health disparities, particularly those that use a Community-Based Participatory Research (CBPR) approach. Her research has combined my knowledge and interest in CBPR with an interest in the intersection of environmental health and social and behavioral aspects of human behavior, from individual to policy level. Recently, her research has also focused on rural health, particularly rural health disparities. She leads the Cancer Drivers in Iowa initiative, a collaborative, state-led effort to examine why cancer incidence is high in Iowa and to identify the underlying behavioral, environmental, and genetic factors. Additionally, she previously served as the EHSRC’s Community Engagement Core director. Publications: Dr. Peters is engaged in research on the mechanics of aerosols, including sampling and transport, instrumentation, and filter design. In addition, he conducts studies on industrial ventilation and the capture and control of workplace pollutants. He is also interested in the design of detectors and control strategies for harmful bioaerosol agents. Current projects include Ultrafine Particles in Heavy Vehicle Manufacturing; Ambient Particle Monitoring with Passive Samplers, and; Airway and Immune Response to Inhaled Endotoxin and Diesel Exhaust Particles. Dr. Pierce's research seeks to understand the mechanisms that contribute to accelerated vascular aging (assessed by endothelial dysfunction and large central artery stiffness) with sedentary aging, hypertension, COPD, and preeclampsia in humans. His lab uses an integrative experimental approach, including non-invasive and semi-invasive approaches to assess vascular function in human subjects and study cells/tissues (endothelial cells, mononuclear cells, sera, adipose) from humans to investigate the cellular and molecular mechanisms involved in abnormal vascular function. Dr. Pierce has specific expertise in measuring vascular endothelial function in humans via brachial artery flow-mediated dilation, limb blood flow using venous occlusion lethysmography and peripheral artery tonometry, and aortic stiffness via pulse wave velocity. In addition, he has conducted small and medium sized singlecenter randomized, controlled intervention studies (e.g., pharmacological, exercise) on vascular endothelial function and arterial stiffness in relation to metabolic, inflammation and oxidative stress outcomes in healthy young, middle-aged and older adults, and patients with end-stage heart failure and heart transplantation. Professor Roesler’s scholarship focuses on issues of environmental governance, land use regulation, and climate policy, often exploring issues at the intersection of environmental regulation and constitutional law. Her work has appeared in edited volumes and leading law journals such as the Georgetown Law Journal, the Florida Law Review, and the U.C. Davis Law Review. She is also a co-author of a property law casebook and co-editor of a volume entitled Adapting to High-Level Warming: Law, Governance, and Equity. Prof. Roesler played an instrumental role in launching the UI's Hubbell Environmental Law Initiative (HELI), which was funded with a $5 million donation from two UI Law alumni, the largest gift in the College of Law's history. As HELI's Faculty Director, Prof. Roesler supports high-impact programming and facilitates campus-wide dialogue on environmental issues, bringing together legal scholars, policymakers, scientists, and community partners. As an EHSRC Member, Prof. Roesler will facilitate new collaborations between the EHSRC and HELI, including cosponsored events, interdisciplinary environmental policy-science exchanges, and student engagement across law, environmental sciences, and public health. Dr. Rohlman is the Associate Dean of Faculty in the College of Public Health and a professor in the Department of Occupational & Environmental Health at the University of Iowa. She also holds the Endowed Chair in Rural Health and Safety. She directs the Healthier Workforce Center of The Midwest, as well as the Agricultural Safety and Health Training Program. Her research focuses on the health effects of occupational and environmental exposures, with emphasis on the increased workplace risks faced by younger employees. Her studies have examined agricultural workers in the United States and around the world, including research on the effects of pesticide exposure on adolescents and their developing nervous system. She also has studied how lifestyle factors and mental health can impact safety on the job, as well as the effect of interventions directed toward supervisors and workplace policies. Thoughout his career, Dr. Roman has focused on investigating novel targets for therapeutic intervention, using high throughput screening as a tool. He has longstanding interests in 1) targeting regulators of GPCR signals as novel drug targets, 2) exploiting novel targets for therapeutic intervention in cancer, 3) the development of novel methodologies to measure protein-protein interactions and function, 4) the design and implementation of high throughput technologies for lead development, and 5) the impact of environmental contaminants such as PFAS on GPCR signaling pathways. Selected Publications: Dr. Paul Romitti is a reproductive molecular epidemiologist with over 30 years of experience in surveillance and research of congenital and inherited disorders and in conducting molecular epidemiology investigations of these outcomes. He directs the Iowa Registry for Congenital and Inherited Disorders and Iowa Center of Excellence for Birth Defects Research and Prevention. As Registry director, Dr. Romitti leads population-based surveillance of major birth defects and maternal and pregnancy outcomes of emerging threats, along with life course surveillance for major birth defects and other congenital and inherited disorders. As Center director, he leads epidemiological studies, high-throughput genomic studies, and studies of gene-environment interaction effects. Dr. Salem’s research expertise encompasses drug discovery, development, formulation, and delivery. He applies this expertise to develop therapies for cancer and other diseases and to advance regenerative medicine. His laboratory investigates how cancer develops and designs new strategies for cancer treatment, including approaches that use polymer particle technology, CpG oligonucleotides, and adenoviruses to generate stronger and more sustained antitumor immune responses. He also conducts federally funded investigations that evaluate the toxicity of chemicals following exposure through a variety of routes, including pulmonary delivery, and develop countermeasures to mitigate the harmful effects of such exposures. Dr. Schnoor conducts research in the areas of environmental health and chemistry, mathematical modeling of natural waters and groundwater, phytoremediation, water sustainability, and climate change. He is a registered professional engineer and a member of the National Academy of Engineering (elected in 1999) for pioneering work using mathematical models in science policy decisions for environmental protection. Dr. Schnoor has testified several times before Congress on pressing environmental health issues, including the environmental effects of acid deposition and the importance of passing the 1990 Clean Air Act. Dr. Schnoor brings expertise to the EHSRC in the areas of chemical exposure assessments, water sustainability and health effects, water quality modeling, and interventions involving phytoremediation. Dr. Schultz is a subject matter expert in radiochemistry, radiopharmaceutical science, environmental radiochemistry, and nuclear science. His research platform includes quantitative redox biology and free radical chemistry toward the development of a more detailed understanding of cancer and for the development of new targeted imaging and therapy agents for cancer. The Shen lab seeks to bridge basic science and health services research by exploring the intersection of nature and nurture in mental health. We draw upon tools and perspectives from a wide range of disciplines (including neuroscience, genomics, and environmental health) to dissect the complex interplay between genes and the environment. We are especially interested in how early-life and cumulative exposures influence later-life outcomes for mood disorders, psychosis, substance use, and neurodegenerative disorders. By identifying cellular endophenotypes and their molecular correlates, we aim to advance the detection and treatment of neuropsychiatric disorders. Complete List of Published Work
Dr. Sieren leads research in quantitative imaging science, developing and validating imaging biomarkers that improve the detection and monitoring of cancer and pulmonary disease. Her work integrates advanced CT technologies, including photon-counting CT, computational image analysis, imaging-pathology correlation, and multicenter clinical trial imaging to accelerate the translation of precision imaging into research and patient care. Dr. Simmering's research uses large administrative health care claims data and modern statistical methods to understand the environmental determinants of health, in particular, respiratory infections (community acquired pneumonia and Legionnaires' disease), chronic lung disorders (COPD and sarcoidosis), and neurodegenerative diseases (Parkinson's disease, Alzheimer's disease). In particular, he is interested in the extent to which seasonal patterns of disease may be driven by changes in pollution, weather, and sunlight. For Dr. Simmering, the use of very large, geographically extensive databases of health insurance claims and medical records provide a critical method for validating insights developed by emerging research in toxicology in the laboratory. Dr. Simmering uses this method to disentangle the constituent elements of an environmental exposure mixture through both modern statistical methods (e.g., Bayesian kernel machine regression, Selected Publications: Dr. Spitz is a well-established investigator studying the role of metabolic oxidative stress in lung cancer biology and therapy as well as radiobiology. His scientific impact on the field includes 1) developing the competitive inhibition superoxide dismutase (SOD) activity assay commonly used today to discriminate between MnSOD and CuZnSOD activity in mammalian tissue homogenates, 2) showing that acute and chronic exposure of mammalian cells in culture to both H2O2 and high levels of O2 induced transient and stable cellular resistance to oxidative stress that was accompanied by profound changes in the expression of many protective proteins and oxidative stress responsive pathways, 3) the discovery that chronic exposure to oxidative stress mediated by H2O2 and high levels of O2 (as well as mutations in mitochondrial electron transport chain proteins) was capable of inducing genomic instability and gene amplification in mammalian cells as well as rendering them cross resistant to agents used to treat cancer, 4) the discovery that glucose deprivation preferentially killed cancer vs. normal cells by metabolic oxidative stress mediated by mitochondrial O2•- and H2O2, 5) the discovery that human tumor cell mitochondria generate greater steady-state levels of O2•-/H2O2, relative to normal cells, that could potentially be exploited for cancer therapy purposes. Dr. Spitz has been a member of the Human Toxicology program for 20 years and has trained several PhD students from that program as well as regularly publishing in the field of toxicology as it relates to Radiation, Cancer and Free Radical Biology. Hanna Stevens runs the Psychiatry and Early Neurobiological Development Lab (PENDL) at the University of Iowa Carver College of Medicine. Her research seeks to understand molecular and cellular aspects of early brain development and their relevance to psychiatric disorders. Her work is particularly focused on understanding how prenatal stress, environmental exposures and genes that play a role in early development have an impact on childhood behavior and act as risk factors for multiple psychiatric disorders. The goal of the lab is to advance mental health diagnosis and treatment of disorders across the lifespan. The lab is particularly focused on the high risk times of pregnancy and early development. Publications: Dr. Stoltz's research focuses on the pathogenesis of cystic fibrosis related airway disease with a particular emphasis on studying airway epithelial and smooth muscle cells, the role of paraoxonases (PONs) on Pseudomonas aeruginosa quorum-sensing regulation, mucociliary clearance, and advanced airway imaging modalities and analysis. In collaboration with other investigators at the University of Iowa, Dr. Stoltz has overseen the development of the CF pig model for over 15 years. He directed and participated in the development of the surgical correction of the meconium ileus Pronouns: she/her/hers Center Affiliation and Expertise: Particle Science Thematic Area Research in the Stone group focuses on the advancement of methodology to study the chemical composition of particulate matter in the atmosphere, or aerosols. Aerosols play an important role in regulating global climate by reflecting solar radiation and altering cloud formation and lifetime. Elevated levels of particulate matter also negatively affect human health. The chemistry of aerosols is complex and varies drastically across different regions of the world. Dr. Stone's research targets the organic fraction of ambient aerosol, which constitutes an average of half of particulate mass and remains the most poorly understood component due to its chemical complexity, variety of sources, and ability to transform in the atmosphere. Her laboratory develops new methodology to study organic compounds and functional groups in aerosols and apply these techniques to different environmental settings. Publications: Dr. Thippeswamy's research focuses on neuroinflammation, epileptogenesis, and neurotoxicity, with the goal of developing disease-modifying therapies for neurotoxins-induced epilepsy, including acute exposure to organophosphates, and related neurological disorders. His NIH-funded program investigates glial-neuronal signaling, nitric oxide synthase, Src/Fyn kinase pathways, oxidative stress, and neurodegeneration in experimental models of epilepsy. His work has led to novel therapeutic discoveries, multiple patents, and translational strategies aimed at preventing epilepsy and mitigating long-term neurological injury. Dr. Thompson’s research focuses on documenting exposure to emerging contaminants and assessing their associated health risks. He is the Associate Director of UI’s Center of Health Effects of Environmental Contamination (CHEEC), a state-sponsored research center focused on improving the environmental quality and public health. His work examines pesticide mixtures and per- and polyfluoroalkyl substances (PFAS) through biomonitoring, environmental monitoring, and epidemiological studies. He is particularly interested in understanding the relationships between these exposures and human health outcomes. Dr. Thorne is University of Iowa Distinguished Chair and Professor in the Department of Occupational and Environmental Health. His research interests are in environmental risk factors for inflammatory lung diseases and immunomodulation, the health impacts of climate-exacerbated disasters, and the toxicity of emerging and persistent environmental pollutants. Dr. Thorne has served the National Academy of Sciences, Engineering and Medicine on their Board on Environmental Studies and Toxicology and as Chair of the Committee on Toxicology and the Aircraft Cabin Air Quality Committee. From 2011 to 2017 and 2021-2025, he served on the U.S. Environmental Protection Agency’s Science Advisory Board (SAB) and served as Chair of the SAB from 2015-2017. Dr. Thorne was a member of the NIH National Advisory Environmental Health Sciences Council from 2003-2007. Dr. Thorne served as EHSRC Director from 2001-2020 and as Deputy Director from 1995-2000 and 2020-2026. He founded the EHSRC's Pulmonary Toxicology Facility (PTF) in 1994 and served as its Director until 2026. In addition to his leadership in the EHSRC and the PTF, Dr. Thorne was principal investigator of the AESOP Project (a community-based research study of PCB exposures) and leads research on the toxicity of inhaled PCB mixtures for the Iowa Superfund Research Program. He also is engaged in the development of medical countermeasures to treat respiratory injuries from chemical threat agent. Dr. Thorne is internationally recognized for his discoveries of the exacerbation of asthma and other respiratory diseases associated with domestic and occupational exposures to bioaerosols. His laboratory collaborates extensively providing exposure assessments for children’s environmental health studies. Dr. Wallace is an emeritus professor of epidemiology and internal medicine. Much of career has been devoted to the study of the chronic diseases of older people and particularly of older women. He has studied the effects of air pollution and other environmental biological and physical hazards on incidence of chronic illnesses, including dementia and cardiovascular diseases. Selected Publications Dr. Wang's current research involves satellite remote sensing and Earth system modeling, focusing on aerosols, radiative transfer, fires, air-land interaction, air quality, and weather. His specialized fields of knowledge include interaction between atmospheric composition and extreme weather; impacts of aerosols on air quality and weather; and interdisciplinary research related to cloud and trace gases, air quality and public health, irrigation, land use, fire, agriculture and extreme weather, as well as solar and wind energy and Earth Science education. Dr. Kai Wang serves as the biostatistician for the Environmental Health Sciences Research Center (EHSRC) and is a Professor of Biostatistics at the University of Iowa. He has extensive expertise in statistical modeling and analysis of complex biomedical and environmental data, including high-dimensional omics data (genomics, sequencing, microarray, and imaging), clustered and correlated data (family studies, repeated measures, and longitudinal data), categorical outcomes, and time-to-event data. Dr. Wang directs the Data Management and Analysis Core of the Iowa Superfund Research Program, which focuses on polychlorinated biphenyls (PCBs) and other environmental pollutants. He is actively engaged in methodological research, with recent work emphasizing mediation analysis, Mendelian randomization, and spatial transcriptomics. Dr. Wang has authored more than 200 peer-reviewed publications spanning toxicology, environmental health sciences, biostatistics, and bioinformatics. He also serves on the editorial boards of Briefings in Bioinformatics and PLOS Genetics. Dr. Watkins is a scholar of public health whose work aims to illuminate social and structural barriers that individuals face in achieving their full health potential in order to inform efforts that promote health equity. Her current work investigates patterns of tobacco initiation, progression, product switching, and cessation, with specific interests in adolescent and young adults, non-cigarette tobacco products (e.g. e-cigarettes), characterizing flavors, and co-use with cannabis. This work informs interventions to promote cancer prevention and reduce tobacco-related health disparities. Another thread of research has focused on urban environments, particularly understanding social and environmental impacts of citizen engagement in caring for urban environmental resources and evaluating evidence, determinants, and outcomes of urban forest inequity. She approaches her research with an interdisciplinary lens and employs a variety of methodological approaches, including epidemiological and econometric techniques, qualitative methods, meta-analysis, and spatial analysis. A core component of her research program is engagement with public and policy stakeholders and public dissemination of her work. Dr. Weiner is an active translational cancer investigator who has been on the faculty at the University of Iowa since 1989. He served as Director of the Holden Comprehensive Cancer Center (HCCC) from 1999 until April 2023 and led the Cancer Center to recognition as an NCI-designated comprehensive cancer center in 2000. This designation was renewed in 2005, 2011, 2016 and 2021. Dr. Weiner’s translational research centers on the relationship between the tumor microenvironment and cancer immunotherapy. This includes laboratory projects exploring novel approaches to cancer immunotherapy and evaluation of the mechanisms of response and resistance to cancer. The laboratory uses molecular and cellular techniques as well as model systems and is extensively involved in analysis of correlative clinical samples. The Welsh laboratory emphasizes research in two main areas. The first focuses on cystic fibrosis (CF), a common lethal genetic disease in which lung disease is the major cause of morbidity and mortality. Welsh and his colleagues are discovering the pathogenesis of airway disease, elucidating the impact of environmental exposures on disease pathogenesis and respiratory defenses, and developing novel treatments. The second focuses on neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. Welsh and his colleagues are investigating the pathophysiological basis of protein aggregates and developing treatments to prevent or delay the progressive neuron loss. Center Affiliation and Expertise: Inflammation and Innate Immunity Dr. Zabner has significant experience at basic CF research, clinical CF research, and the care of patients with lung disease, including CF. Several aspects of his research would be best classified as translational research. His basic research focuses in two areas, gene transfer to airway epithelia, including the basic mechanisms and development of new approaches to gene transfer, and investigation of the pathogenesis of CF airway disease, including mechanisms of electrolyte transport and bacterial killing. The main goal of his current gene therapy efforts include work is to improve efficiency of adenovirus-mediated gene transfer to the airways. Dr. Zabner's laboratory is also involved in delineating mechanisms of altered NaCl concentration in the airway surface fluid (ASF) of CF as compared to non-CF epithelia. To address these questions, he uses primary cultures of normal and CF airway epithelia to measure ion concentrations of ASF. Three different methods including ion-selective electrodes, measurement of ASF in which the capillary pressure of the cilia is replaced by osmotic pressure from a non-absorbed osmolyte, and radioactive tracers studied at equilibrium, are used to address these issues. The results of these studied are central to understanding how the lack of CFTR Cl- channels causes CF lung disease. http://www.healthcare.uiowa.edu/labs/zabner/
Professor of Occupational and Environmental Health; Center Director; Co-Leader, Water Quality Thematic Area (WQ-TA)
Hans-Joachim Lehmler, PhD
Professor of Community and Behavioral Health
Sato Ashida, PhD
Research Assistant Professor, Occupational and Environmental Health; Director, Pulmonary Toxicology Facility
Andrea Adamcakova-Dodd, PhD
Associate Research Engineer, Civil and Environmental Engineering
Andres Martinez Araneda, PhD
Assistant Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine
Robert J. Blount, MD, MAS
Professor of Radiation Oncology; Director, Free Radical and Radiation Biology Program
Andrean Simons-Burnett, PhD
Assistant Professor of Neuroscience and Pharmacology
Snehajyoti Chatterjee, PhD
Associate Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine; Co-Leader, Inflammation and Innate Immunity Thematic Area (III-TA)
Josalyn Cho, MD
Clinical Professor, Internal Medicine - Pulmonary, Critical Care and Occupational Medicine; Director, Translational Research Support Core (TRSC); Co-Leader, Population Health Thematic Area (PH-TA)
Alejandro Comellas, MD
Professor of Biology
Josep Comeron, PhD
Professor of Civil and Environmental Engineering; Co-Leader, Water Quality Thematic Area (WQ-TA)
David M. Cwiertny, PhD
Assistant Professor of Occupational and Environmental Health
Kathryn Dalton, PhD, VMD, MPH
Professor of Pharmaceutical Sciences and Experimental Therapeutics
Maureen Donovan, PhD
Professor, Pharmaceutical Sciences and Experimental Therapeutics; Co-Leader, Systemic and Redox Toxicology Thematic Area (SART-TA)
Jonathan A. Doorn, PhD
Assistant Professor of Epidemiology
Shoshannah Eggers, PhD
Professor and Vice Chair for Research, Radiology - Division of Cardiovascular and Thoracic Imaging
Sean B. Fain, PhD
Director, Great Plains Center for Agricultural Health; Professor and Department Head, Occupational and Environmental Health
Nathan Fethke, MS, PhD
Assistant Professor of Epidemiology
John C. Flunker, PhD, MPH, MS
Professor of Chemistry
Tori Z. Forbes, PhD
Assistant Professor of Pharmaceutical Sciences and Experimental Therapeutics
Marie Gaine, PhD
Associate Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine
Alicia K. Gerke, MD, MBA
Professor and Richard Hichwa Chair, Radiology - Division of Cardiovascular and Thoracic Imaging; Co-Director/Imaging Director, Translational Research Support Core
Eric A. Hoffman, PhD
University of Iowa Distinguished Chair and Professor, Civil and Environmental Engineering
Keri C. Hornbuckle, PhD
Clinical Professor of Occupational and Environmental Health; Center Deputy Director; Community Engagement Core Director; Co-Leader, Population Health Thematic Area (PH-TA)
Brandi Janssen, PhD
Donald E. Bently Professor in Engineering, Professor of Civil and Environmental Engineering
Craig L. Just, PhD
Professor of Animal Science, Iowa State University; Co-Leader, Systemic and Redox Toxicology Thematic Area
Aileen Keating, MS, PhD
Associate Professor of Occupational and Environmental Health; Director, Pilot Grant Program
Jong-Sung Kim, PhD
Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine
Julia Klesney-Tait, MD, PhD
Professor of Microbiology and Immunology
Aloysius J. Klingelhutz, PhD
Associate Professor of Civil and Environmental Engineering
Gregory H. LeFevre, PhD
Professor and Departmental Executive Officer, Mechanical and Industrial Engineering
Ching-Long Lin, PhD
Professor Emeritus of Epidemiology
Charles F. Lynch, MD, PhD
2. Lee S, Shu X, Derkach A, Reiner AS, Liang X, Woods M, Concannon P, Lynch CF, Malone KE, Knight JA, John EM, Deasy JO, Bernstein JL, Oh JH. Integrating genomic and non-genomic data to stratify the risk of contralateral breast cancer after radiotherapy. International Journal of Radiation Oncology, Biology and Physics 2026 Aug 1;125(5):1512-1521. PMID41763494, PMC13051349
3. Tao J, Pfeiffer R, Ahmed S, Luo Q, Qian B, Lynch CF, Insaf T, Ramirez-Aguilar D, Israni A, Morton LM, Engels EA. Cancer risk in solid organ transplant recipients with a pretransplant cancer history. JAMA Oncology 2026 May 1;12(5):470-477. PMID41817522, PMC13195476
4. Naderi E, Watt GP, Knight JA, Malone KE, Lynch CF, John EM, Shu X, Nguyen TL, Oh JH, Woods M, Liang X, Derkach A, Pike MC, Bernstein JL Evaluating mammographic density polygenic risk score for contralateral breast cancer risk prediction. Scientific Reports 2026 Mar 4;16(1):12125. PMID41781474
5. Watt GP, Reiner AS, Shu X, Malone KE, Knight JA, John EM, Chow EJ, Lynch CF, Mellemkjær L, Woods M, Liang X, Tran AP, Oh JH, Derkach A, Bernstein JL. Polygenic risk of coronary artery disease for long-term survivors of breast cancer. Journal of the National Cancer Institute 2025 Oct 1;117(10):2073-2081. PMID40665521, PMC12505140
6. Ahmed S, Pfeiffer RM, Volesky-Avellaneda K, Blosser CD, Snyder JJ, Israni AK, Lynch CF, Qiao B, Rees JR, Zwald F, Yu KJ, Engels EA. Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United States. American Journal of Transplantation 2025 Aug;25(8):1723-1734. PMID40064297, PMC12310376 (Editor's Choice article for the March issue)
7. Jackson SS, Pfeiffer RM, Gardner E, Hsieh MC, Insaf T, Lynch CF, B Morawski, Wang S, Yu KJ, Engels EA. Sex differences in cancer survival among solid organ transplant recipients. International Journal of Cancer 2025 Aug 1;157(3):427-435. PMID40347031, PMC12143962
8. Engels EA, Mandal S, Corley DA, Blosser CD, Hart A, Lynch CF, Qiao B, Pawlish KS, Haber G, Yu KJ, Pfeiffer RM. Cure models, survival probabilities, and solid organ transplantation for patients with colorectal cancer. American Journal of Transplantation 2025 Mar;25(3):545-555. PMID39182612, PMC11842210
9. Debeljak M, Cho S, Downs BM, Considine M, Avin-McKelvey B, Wang Y, Perez PN, Grizzle WE, Hoadley KA, Lynch CF, Hernandez BY, van Diest PJ, Cozen W, Hamilton AS, Hawes D, Gabrielson E, Cimino-Mathews A, Florea LD, Cope L, Umbricht CB. Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ. Breast Cancer Research 2024 Dec 4;26(1):178. PMID39633428
10. Reiner AS, Watt GP, Malone KE, Lynch CF, John EM, Knight JA, Woods M, Liang X, Tishkowitz M, Conti DV, Robson ME, Mellemkjær L, Teraoka SN, Concannon P, Bernstein JL. Breast cancer susceptibility gene sequence variations and development of contralateral breast cancer. JAMA Network Open 2024 Dec 2;7(12):e2452158. PMID39786405
11. Starrett GJ, Baikie BC, Stoff BK, Grossniklaus HE, Van Buren I, Berry EG, Novoa RA, Rieger KE, Sarin KY, Lynch CF, Royer MC, Piaskowski ML, Brownell I, Chu EY, Godse R, Chen SC, Yu KJ, Goldstein AM, Engels EA, Sargen MR. Multiomics profiling distinguishes sebaceous carcinoma from benign sebaceous neoplasms and provides insight into the genetic evolution of sebaceous carcinogenesis. Clinical Cancer Research 2024 Nov 1;30(21):4887-4899. PMID39287419, PMC11530307
12. Dennis LK, Langston ME, Beane Freeman L, Canales RA, Lynch CF. Trace element concentrations of arsenic and selenium in toenails and risk of prostate cancer among pesticide applicators. Current Oncology 2024 Sep 14;31(9):5472-5483. PMID39330033
13. Sanchez P, Van Dyke AL, Petkov VI, Yuan Y, Bonds S, Valenzuela C, Tuan AW, Moravec R, Altekruse SF, Singhi AD, Serdy KM, Wu Y, Cress RD, Doherty JA, Mueller L, Hernandex BY, Lynch CF, Tucker TC, Wu XC, Matrisian L, Penberthy L. NCI SEER-linked virtual tissue repository pilot. J Natl Cancer Inst Monographs 2024 Aug 1;2024(65):180-190. PMID39102878
14. Sun X, Verma SP, Jia G, Wang X, Ping J, Guo X, Shu XO, Chen J, Derkach A, Cai Q, Liang X, Long J, Offit K, Oh JH, Reiner AS, Watt GP, Woods M, Yang Y, Ambrosone CB, Ambs S, Chen Y, Concannon P, Garcia-Closas M, Gu J, Haiman CA, Hu JJ, Huo D, John EM, Knight JA, Li CI, Lynch CF, Mellemkjaer L, Nathanson KL, Nemesure B, Olopade OI, Olshan AF, Pal T, Palmer JR, Press MF, Sanderson M, Sandler DP, Troester MA, Zheng W, Bernstein JL, Buas MF, Shu X. Case-case genome-wide analyses identify subtype-informative variants that confer risk for breast cancer. Cancer Research 2024 Aug 1;84(15):2533-2548. PMID38832928, PMC11293972
15. Zwald FO, Sargen MR, Austin AA, Hsieh MC, Pawlish K, Li J, Lynch CF, Yu KJ, Engels EA. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma. American Journal of Transplantation 2024 Jun;24(6):993-1002. PMID38387619, PMC11144558
16. Sun X, Reiner AS, Tran AP, Watt GP, Oh JH, Mellemkjær L, Lynch CF, Knight JA, John EM, Malone KE, Liang X, Woods M, Derkach A, Concannon P, Bernstein JL, Shu X. A genome-wide association study of contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study. Breast Cancer Research 2024 Jan 23;26(1):16. PMID38263039
17. Mix JM, Miller MJ,Querec TD, Darragh TM, Saraiya M, Gopalani SV, Lynch CF, Thompson TD, Greek A, Tucker TC, Peters ES, Unger ER. Human Papillomavirus Detection in Scrotal Squamous Cell Carcinoma: Case Series from a Population-Based Cancer Registry. Journal of Registry Management 2023 Winter;50(4):116-121. PMID38504701
18. Wang JH, Pfeiffer RM, Musgrove D, Castenson D, Frederickson M, Miller J, Gonsalves L, Hsieh MC, Lynch CF, Zeng Y, Yu KJ, Hart A, Israni AK, Snyder JJ, Engels EA. Cancer mortality among solid organ transplant recipients in the United States during 1987-2018. Transplantation 2023 Nov 1;107(11):2433-2442. PMID37291711, PMC10615843
19. Watt GP, Smith SA, Howell RM, Pérez-Andújar A, Reiner AS, Cerviño L, McCormick B, Hess D, Knight JA, Malone KE, John EM, Bernstein L, Lynch CF, Mellemkjær L, Shore RE, Liang X, Woods M, Boice JD, Dauer LT, Bernstein JL. Trends in radiation dose to the contralateral breast during breast radiation therapy. Radiation Research 2023 Oct 1;200(4):331-339. PMID37590492, PMC10684055
20. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Siburg-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology 2023 41(17):3081-3088. PMID37285653, PMC10538911 Corrected and republished from Journal of Clinical Oncology 29(32):4294-4301, 2011.
21. Sadeghi H, Charles Lynch, Field W, Snetselaar L, Jones M, Sinha R, Torner J. Dietary omega-6/omega-3 fatty acids and risk of prostate cancer; Is there .any potential interaction by organophosphate insecticides among the Agricultural Health Study population. Cancer Epidemiology 2023 Aug;85:102410. PMID37413804, PMC10528409
22. Tanaka T, Lynch CF, Yu K, Morawski BM, Hsieh MC, Alverson G, Austin AA, Zeng Y, Engels EA. Pancreatic cancer among solid organ transplant recipients in the United States. Journal of Cancer Research and Clinical Oncology 2023 Jul;149(7):3325-3333. PMID35932302
23. Starrett GJ, Yu K, Golubeva Y, Lenz P, Piaskowski ML, Petersen D, Dean M, Israni A, Hernandez BY, Tucker TC, Cheng I, Gonsalves L, Morris CR, Hussain SK, Lynch CF, Harris RS, Prokunina-Olsson L, Meltzer PS, Buck CB, Engels EA. Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients. eLife 2023 Mar 24;12:e82690. PMID36961501
24. Hart A, Pfeiffer RM, Morawski BM, Lynch CF, Zeng Y, Pawlish K, Hurley D, Yu KJ, Engels EA. Mortality in solid organ transplant recipients with a pretransplant cancer diagnosis. American Journal of Transplantation 2023 Feb;23(2):257-264. PMID36804133, PMC9978936
25. Watt GP, Knight JA, Nguyen TL, Reiner AS, Malone KE, John EM, Lynch CF, Brooks JD, Woods M, Liang X, Bernstein L, Pike MC, Hopper JL, Bernstein JL. Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds. International Journal of Cancer 2022 Oct 15;151(8):1304-1309. PMID35315524
26. Riley D, Charlton M, Chrischilles EA; Lizarraga IM, Phadke S; Smith BJ, Skibbe A, Lynch CF. Hospital rurality and gene expression profiling for early-stage breast cancer among Iowa residents, 2010-2018. The Breast Journal Aug 30;2022:8582894. PMID36111211
27. Engels EA, Fraser GE, Kasiske BL, Snyder JJ, Utt J, Lynch CF, Li J, Pawlish KS, Brown S, Yu KJ, Pfeiffer RM. Cancer risk in living kidney donors. American Journal of Transplantation 2022 Aug;22(8):2006-2015. PMID35510728, (featured on the cover of the August issue)
28. Riley D, Chrischilles EA, Lizarraga IM, Charlton M, Smith BJ, Lynch C. Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis. Cancer Medicine 2022 Jun;11(11):2284–2295. PMID35146946
29. Reiner AS, Watt GP, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Smith SA, Liang X, Woods M, Shore R, Malone KE, Bernstein L; WECARE Collaborative Study Group, Bernstein JL. Smoking, radiation therapy, and contralateral breast cancer risk in young women. Journal of the National Cancer Institute 2022 Apr 11;114(4):631-634. PMID33779721
30. Sargen MR, Cahoon EK, Yu KJ, Madeleine MM , Zeng Y, Rees JR, Lynch CF, Engels EA. Spectrum of nonkeratinocyte skin cancer risk among solid organ transplant recipients in the US. JAMA Dermatology 2022 Apr 1;158(4):414-425. PMID35262623, PMC8908231
31. Riley D, Chrischilles EA, Lizarraga IM, Charlton M, Smith BJ, Lynch CF. Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000-2015. Breast Cancer Research and Treatment 2022 Feb;192(1):211-222. PMID35067778
32. Langston ME, Brown HE, Lynch CF, Roe DJ, Dennis LK. Ambient UVR and environmental arsenic exposure in relation to cutaneous melanoma in Iowa. International Journal of Environmental Research and Public Health 2022 Feb 3;19(3):1742. PMID35162766
33. Weeks KS, Lynch CF, West M, Carnahan R, O’Rorke M, Oleson J, McDonald M, Stewart SL, Ovarian Cancer Treatment Study, Charlton M. Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients. Gynecologic Oncology 2022 Jan;164(1):3-11 (Editor’s Choice article for the January 2022 issue). PMID34776243
34. Noone AM, Pfeiffer RM, Schaubel DE, Dorgan JF, Magder LS, Bromberg JS, Lynch CF, Morris CR, Pawlish KS, Engels EA. Life-years lost to cancer among solid organ transplant recipients in the United Sates, 1987 to 2014. Cancer 2022 Jan 1;128(1):150-159. PMID34541673
Professor of Pathology
Ashutosh Mangalam, PhD
Professor of Civil and Environmental Engineering
Timothy Mattes, PhD
Professor of Pediatrics - Pulmonary Medicine; Co-Leader, Inflammation and Innate Immunity Thematic Area (III-TA)
Paul B. McCray, MD
Professor of Occupational and Environmental Health; Director, Exposure Science Facility (ESF)
Patrick T. O’Shaughnessy, PhD
Assistant Professor of Occupational and Environmental Health
Jin Pan, MS, PhD
Dean, College of Public Health; Professor of Community and Behavioral Health
Edith A. Parker, MPH, DrPH
Professor of Occupational & Environmental Health
Thomas M. Peters, PhD
Departmental Executive Officer and Professor, Department of Health, Sport, and Human Physiology
Gary L. Pierce, PhD
Charlotte and Frederick Hubbell Professor of Environmental and Natural Resources Law
Shannon Roesler, JD, LLM, MA
Professor and Endowed Chair, Occupational and Environmental Health
Diane S. Rohlman, PhD
Professor of Pharmaceutical Sciences and Experimental Therapeutics; Associate Dean for Research, College of Pharmacy
David L. Roman, PhD
Professor of Epidemiology
Paul A. Romitti, PhD
Professor of Pharmaceutical Sciences; Senior Associate Vice President for Research; Co-Leader, Particle Science Thematic Area (PS-TA)
Aliasger Salem, PhD
Professor Emeritus of Civil and Environmental Engineering
Jerald L. Schnoor, PhD
Co-Founder and Chief Science Officer, Perspective Therapeutics, Inc.; Associate Professor Emeritus of Radiology
Michael K. Schultz, PhD
Psychiatry Assistant Professor
Susan Shen, MD, PhD
Associate Professor of Radiology - Division of Cardiovascular and Thoracic Imaging
Jessica C. Sieren, PhD
Assistant Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine
Jacob Simmering, PhD
generalized weighted quantile sum regression) and "experimental" design.
Professor of Radiation Oncology
Douglas R. Spitz, PhD
Professor of Psychiatry
Hanna Stevens, MD, PhD
Professor of Internal Medicine - Pulmonary, Critical Care and Occupational Medicine
David A. Stoltz, MD, PhD
phenotype followed by the genetic correction of this phenotype. A major goal of his current research is to better understand the role of CFTR in airway epithelial, mucus, and smooth muscle cell biology, using a variety of techniques and complementary approaches.
Professor of Chemistry
Betsy Stone, PhD
W. E. Lloyd Endowed Professor in Veterinary Medicine, Iowa State University
Thimmasettappa Thippeswamy, DVM, MVSc, PhD, PgCert HE & TL
Associate Director, Center for Health Effects of Environmental Contamination (CHEEC), University of Iowa
Darrin Thompson, PhD
University of Iowa Distinguished Chair and Professor, Occupational and Environmental Health; Center Associate Director; Co-Director, Pulmonary Toxicology Facility; Co-Leader, Particle Science Thematic Area (PS-TA)
Peter S. Thorne, PhD
Professor Emeritus of Epidemiology
Robert B. Wallace, MS, MD
Departmental Executive Officer and Professor, Chemical and Biochemical Engineering
Jun Wang, PhD, MS
Professor of Biostatistics; Biostatistician, Translational Research Support Core (TRSC)
Kai Wang, PhD
Associate Professor of Community and Behavioral Health
Shannon Lea Watkins, PhD
Director Emeritus, Holden Comprehensive Cancer Center; Professor of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation
George J. Weiner, MD
Professor of Internal Medicine - Pulmonary; Investigator, Howard Hughes Medical Institute
Michael J. Welsh, MD
Professor of Internal Medicine - Pulmonary
Joseph Zabner, MD